Molecular pathological epidemiology research on pancreatic tumors

Molecular pathological epidemiology research on pancreatic tumors - MPE of pancreatic tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044027

Enrollment

2000

Registered

2021-05-01

Start date

2019-09-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent endoscopic or percutaneous biopsy or surgical resection of pancreatic tumors

Exclusion criteria

Exclusion criteria: Patients who researchers consider as ineligible or those who opt out of participant in this study

Design outcomes

Primary

Measure	Time frame
Epidemiological, clinical, pathological, and molecular characteristics and survival outcomes (e.g., disease-free survival, overall survival)	—

Secondary

Measure	Time frame
Response to chemotherapy, patterns of postoperative recurrence, and others	—

Countries

Japan

Contacts

Public ContactTsuyoshi Hamada

Graduate School of Medicine, The University of Tokyo Department of Gastroenterology

hamada-tky@umin.ac.jp03-3815-5411

Outcome results